XML 24 R89.htm IDEA: XBRL DOCUMENT v3.3.0.814
Supplemental Guarantor Financial Information - Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 9 Months Ended
Aug. 17, 2015
May. 18, 2015
Feb. 17, 2015
Nov. 17, 2014
Aug. 18, 2014
May. 16, 2014
Mar. 28, 2014
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:                  
Net cash provided by (used in) continuing operations               $ 312,360 $ 276,168
Net cash provided by discontinued operations               3,441 3,954
Net cash provided by operating activities               315,801 280,122
Cash flows from investing activities:                  
Capital expenditures               (350,253) (385,739)
Proceeds from sale of property, plant and equipment               21,856 19,736
Payment for business acquisitions               0 (494,755)
Capital distributions received from consolidated subsidiaries               0 0
Return of investments in non-consolidated affiliates               15,185 14,750
Proceeds received from settlement of note receivable               5,357 0
Investment in consolidated subsidiaries                 0
Increase in restricted cash               (1) (245)
Cash invested in non-consolidated affiliates               (33) (197)
Return of investments in consolidated subsidiaries               0 0
Net cash used in continuing operations               (307,889) (846,450)
Net cash provided by discontinued operations               33,119 49,835
Net cash used in investing activities               (274,770) (796,615)
Cash flows from financing activities:                  
Proceeds from borrowings of long-term debt               1,055,000 1,849,799
Repayments of long-term debt               (1,006,500) (1,406,000)
Payments for debt issuance costs               (3,208) (6,923)
Payments above face value for redemption of convertible debt               0 (15,007)
Payments for settlement of interest rate swaps that include financing elements               (2,815) (2,844)
Net proceeds from the sale of Partnership units               1,164 169,471
Proceeds from stock options exercised               1,106 11,637
Proceeds from stock issued pursuant to our employee stock purchase plan               910 1,324
Purchases of treasury stock               (3,771) (6,372)
Dividends to Exterran stockholders $ (10,500) $ (10,400) $ (10,300) $ (10,300) $ (10,000) $ (10,000) $ (10,000) (31,167) (30,047)
Stock-based compensation excess tax benefit               3,048 8,269
Distributions to noncontrolling partners in the Partnership               (61,045) (54,893)
Net proceeds from sale of general partner units                 0
Capital distributions to affiliates               0 0
Capital contributions received from parent                 0
Borrowings (repayments) between consolidated subsidiaries, net               0 0
Net cash provided by (used in) financing activities               (47,278) 518,414
Effect of exchange rate changes on cash and cash equivalents               (976) (3,797)
Net increase (decrease) in cash and cash equivalents               (7,223) (1,876)
Cash and cash equivalents at beginning of period               39,739 35,665
Cash and cash equivalents at end of period               32,516 33,789
Eliminations                  
Cash flows from operating activities:                  
Net cash provided by (used in) continuing operations               0 0
Net cash provided by discontinued operations               0 0
Net cash provided by operating activities               0 0
Cash flows from investing activities:                  
Capital expenditures               0 0
Proceeds from sale of property, plant and equipment               0 0
Payment for business acquisitions                 0
Capital distributions received from consolidated subsidiaries               (49,265) (40,688)
Return of investments in non-consolidated affiliates               0 0
Proceeds received from settlement of note receivable               0  
Investment in consolidated subsidiaries                 13,813
Increase in restricted cash               0 0
Cash invested in non-consolidated affiliates               0 0
Return of investments in consolidated subsidiaries               (31,167) (252,482)
Net cash used in continuing operations               (80,432) (279,357)
Net cash provided by discontinued operations               0 0
Net cash used in investing activities               (80,432) (279,357)
Cash flows from financing activities:                  
Proceeds from borrowings of long-term debt               0 0
Repayments of long-term debt               0 0
Payments for debt issuance costs               0 0
Payments above face value for redemption of convertible debt                 0
Payments for settlement of interest rate swaps that include financing elements               0 0
Net proceeds from the sale of Partnership units               0 0
Proceeds from stock options exercised               0 0
Proceeds from stock issued pursuant to our employee stock purchase plan               0 0
Purchases of treasury stock               0 0
Dividends to Exterran stockholders               0 0
Stock-based compensation excess tax benefit               0 0
Distributions to noncontrolling partners in the Partnership               49,265 40,688
Net proceeds from sale of general partner units                 (3,573)
Capital distributions to affiliates               31,167 252,482
Capital contributions received from parent                 (10,240)
Borrowings (repayments) between consolidated subsidiaries, net               0 0
Net cash provided by (used in) financing activities               80,432 279,357
Effect of exchange rate changes on cash and cash equivalents               0 0
Net increase (decrease) in cash and cash equivalents               0 0
Cash and cash equivalents at beginning of period               0 0
Cash and cash equivalents at end of period               0 0
Parent | Reportable Legal Entities                  
Cash flows from operating activities:                  
Net cash provided by (used in) continuing operations               3,629 (1,743)
Net cash provided by discontinued operations               0 0
Net cash provided by operating activities               3,629 (1,743)
Cash flows from investing activities:                  
Capital expenditures               0 0
Proceeds from sale of property, plant and equipment               0 0
Payment for business acquisitions                 0
Capital distributions received from consolidated subsidiaries               0 0
Return of investments in non-consolidated affiliates               0 0
Proceeds received from settlement of note receivable               0  
Investment in consolidated subsidiaries                 0
Increase in restricted cash               0 0
Cash invested in non-consolidated affiliates               0 0
Return of investments in consolidated subsidiaries               31,167 252,482
Net cash used in continuing operations               31,167 252,482
Net cash provided by discontinued operations               0 0
Net cash used in investing activities               31,167 252,482
Cash flows from financing activities:                  
Proceeds from borrowings of long-term debt               722,500 1,056,001
Repayments of long-term debt               (768,000) (1,073,500)
Payments for debt issuance costs               (874) 0
Payments above face value for redemption of convertible debt                 (15,007)
Payments for settlement of interest rate swaps that include financing elements               0 0
Net proceeds from the sale of Partnership units               0 0
Proceeds from stock options exercised               1,106 11,637
Proceeds from stock issued pursuant to our employee stock purchase plan               910 1,324
Purchases of treasury stock               (3,771) (6,372)
Dividends to Exterran stockholders               (31,167) (30,047)
Stock-based compensation excess tax benefit               3,048 8,269
Distributions to noncontrolling partners in the Partnership               0 0
Net proceeds from sale of general partner units                 0
Capital distributions to affiliates               0 0
Capital contributions received from parent                 0
Borrowings (repayments) between consolidated subsidiaries, net               41,550 (203,025)
Net cash provided by (used in) financing activities               (34,698) (250,720)
Effect of exchange rate changes on cash and cash equivalents               0 0
Net increase (decrease) in cash and cash equivalents               98 19
Cash and cash equivalents at beginning of period               42 11
Cash and cash equivalents at end of period               140 30
Guarantor Subsidiaries | Reportable Legal Entities                  
Cash flows from operating activities:                  
Net cash provided by (used in) continuing operations               2,269 79,455
Net cash provided by discontinued operations               0 0
Net cash provided by operating activities               2,269 79,455
Cash flows from investing activities:                  
Capital expenditures               (77,179) (116,458)
Proceeds from sale of property, plant and equipment               4,630 8,274
Payment for business acquisitions                 (11,743)
Capital distributions received from consolidated subsidiaries               49,265 40,688
Return of investments in non-consolidated affiliates               0 0
Proceeds received from settlement of note receivable               0  
Investment in consolidated subsidiaries                 (13,813)
Increase in restricted cash               0 0
Cash invested in non-consolidated affiliates               0 0
Return of investments in consolidated subsidiaries               0 0
Net cash used in continuing operations               (23,284) (93,052)
Net cash provided by discontinued operations               0 0
Net cash used in investing activities               (23,284) (93,052)
Cash flows from financing activities:                  
Proceeds from borrowings of long-term debt               0 0
Repayments of long-term debt               0 0
Payments for debt issuance costs               (1,023) 0
Payments above face value for redemption of convertible debt                 0
Payments for settlement of interest rate swaps that include financing elements               0 0
Net proceeds from the sale of Partnership units               0 0
Proceeds from stock options exercised               0 0
Proceeds from stock issued pursuant to our employee stock purchase plan               0 0
Purchases of treasury stock               0 0
Dividends to Exterran stockholders               0 0
Stock-based compensation excess tax benefit               0 0
Distributions to noncontrolling partners in the Partnership               0 0
Net proceeds from sale of general partner units                 0
Capital distributions to affiliates               (31,167) (252,482)
Capital contributions received from parent                 0
Borrowings (repayments) between consolidated subsidiaries, net               53,531 264,974
Net cash provided by (used in) financing activities               21,341 12,492
Effect of exchange rate changes on cash and cash equivalents               0 0
Net increase (decrease) in cash and cash equivalents               326 (1,105)
Cash and cash equivalents at beginning of period               655 1,554
Cash and cash equivalents at end of period               981 449
Other Subsidiaries | Reportable Legal Entities                  
Cash flows from operating activities:                  
Net cash provided by (used in) continuing operations               306,462 198,456
Net cash provided by discontinued operations               3,441 3,954
Net cash provided by operating activities               309,903 202,410
Cash flows from investing activities:                  
Capital expenditures               (273,074) (269,281)
Proceeds from sale of property, plant and equipment               17,226 11,462
Payment for business acquisitions                 (483,012)
Capital distributions received from consolidated subsidiaries               0 0
Return of investments in non-consolidated affiliates               15,185 14,750
Proceeds received from settlement of note receivable               5,357  
Investment in consolidated subsidiaries                 0
Increase in restricted cash               (1) (245)
Cash invested in non-consolidated affiliates               (33) (197)
Return of investments in consolidated subsidiaries               0 0
Net cash used in continuing operations               (235,340) (726,523)
Net cash provided by discontinued operations               33,119 49,835
Net cash used in investing activities               (202,221) (676,688)
Cash flows from financing activities:                  
Proceeds from borrowings of long-term debt               332,500 793,798
Repayments of long-term debt               (238,500) (332,500)
Payments for debt issuance costs               (1,311) (6,923)
Payments above face value for redemption of convertible debt                 0
Payments for settlement of interest rate swaps that include financing elements               (2,815) (2,844)
Net proceeds from the sale of Partnership units               1,164 169,471
Proceeds from stock options exercised               0 0
Proceeds from stock issued pursuant to our employee stock purchase plan               0 0
Purchases of treasury stock               0 0
Dividends to Exterran stockholders               0 0
Stock-based compensation excess tax benefit               0 0
Distributions to noncontrolling partners in the Partnership               (110,310) (95,581)
Net proceeds from sale of general partner units                 3,573
Capital distributions to affiliates               0 0
Capital contributions received from parent                 10,240
Borrowings (repayments) between consolidated subsidiaries, net               (95,081) (61,949)
Net cash provided by (used in) financing activities               (114,353) 477,285
Effect of exchange rate changes on cash and cash equivalents               (976) (3,797)
Net increase (decrease) in cash and cash equivalents               (7,647) (790)
Cash and cash equivalents at beginning of period               39,042 34,100
Cash and cash equivalents at end of period               $ 31,395 $ 33,310